Australia · Delayed Price · Currency is AUD Algorae Pharmaceuticals Statistics
Total Valuation
ASX:1AI has a market cap or net worth of AUD 25.62 million. The enterprise value is 23.73 million.
| Market Cap | 25.62M |
| Enterprise Value | 23.73M |
Important Dates
The last earnings date was Tuesday, February 24, 2026.
| Earnings Date | Feb 24, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ASX:1AI has 1.71 billion shares outstanding. The number of shares has increased by 4.60% in one year.
| Current Share Class | 1.71B |
| Shares Outstanding | 1.71B |
| Shares Change (YoY) | +4.60% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 17.29% |
| Owned by Institutions (%) | 2.40% |
| Float | 1.09B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | -979.32 |
| PB Ratio | 13.56 |
| P/TBV Ratio | 13.56 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -23.40 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 17.99
| Current Ratio | 17.99 |
| Quick Ratio | 17.18 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -488.21 |
Financial Efficiency
Return on equity (ROE) is -47.38% and return on invested capital (ROIC) is -42.76%.
| Return on Equity (ROE) | -47.38% |
| Return on Assets (ROA) | -40.34% |
| Return on Invested Capital (ROIC) | -42.76% |
| Return on Capital Employed (ROCE) | -77.50% |
| Weighted Average Cost of Capital (WACC) | 5.23% |
| Revenue Per Employee | -545 |
| Profits Per Employee | -21,128 |
| Employee Count | 48 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.12M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +150.00% in the last 52 weeks. The beta is 0.18, so ASX:1AI's price volatility has been lower than the market average.
| Beta (5Y) | 0.18 |
| 52-Week Price Change | +150.00% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.01 |
| Relative Strength Index (RSI) | 33.60 |
| Average Volume (20 Days) | 1,231,990 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:1AI had revenue of AUD -26,159 and -1.01 million in losses. Loss per share was -0.00.
| Revenue | -26,159 |
| Gross Profit | -26,159 |
| Operating Income | -1.46M |
| Pretax Income | -2.14M |
| Net Income | -1.01M |
| EBITDA | n/a |
| EBIT | -1.46M |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 1.88 million in cash and n/a in debt, with a net cash position of 1.88 million or 0.00 per share.
| Cash & Cash Equivalents | 1.88M |
| Total Debt | n/a |
| Net Cash | 1.88M |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 1.89M |
| Book Value Per Share | 0.00 |
| Working Capital | 1.89M |
Cash Flow
| Operating Cash Flow | -702,896 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | 5,598.91% |
| Pretax Margin | 8,164.68% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ASX:1AI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.60% |
| Shareholder Yield | -4.60% |
| Earnings Yield | -3.96% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |